Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mari N Olsen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Plos Genetics|September 17, 2013
Cell-type specific features of circular RNA expressionJulia Salzman, Raymond E Chen, Mari N Olsen, et al.
Plos One|March 11, 2014
Circular RNA is expressed across the eukaryotic tree of lifePeter L Wang, Yun Bao, Muh-Ching Yee, et al.
Plos One|February 25, 2010
DNA methylation profiles of ovarian epithelial carcinoma tumors and cell linesSahar Houshdaran, Sarah Hawley, Chana Palmer, et al.
The New England Journal of Medicine|June 12, 2024
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell TherapyMark P Hamilton, Takeshi Sugio, Troy Noordenbos, et al.
Cancer Cell|December 30, 2022
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomasBrian J Sworder, David M Kurtz, Stefan K Alig, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Plos Genetics|September 17, 2013
Cell-type specific features of circular RNA expressionJulia Salzman, Raymond E Chen, Mari N Olsen, et al.
Plos One|March 11, 2014
Circular RNA is expressed across the eukaryotic tree of lifePeter L Wang, Yun Bao, Muh-Ching Yee, et al.
Plos One|February 25, 2010
DNA methylation profiles of ovarian epithelial carcinoma tumors and cell linesSahar Houshdaran, Sarah Hawley, Chana Palmer, et al.
The New England Journal of Medicine|June 12, 2024
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell TherapyMark P Hamilton, Takeshi Sugio, Troy Noordenbos, et al.
Cancer Cell|December 30, 2022
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomasBrian J Sworder, David M Kurtz, Stefan K Alig, et al.
Pageof 1